Cargando…
NF-κB Inhibition Suppresses Experimental Melanoma Lung Metastasis
BACKGROUND: Although novel therapeutic regimens for melanoma continue to emerge, the best current clinical response rate is still less than 60%. Moreover, antimelanoma treatments contribute to toxicities in other vital organs. In this study, we elucidate the therapeutic advantages of siRNA targeting...
Autores principales: | Stansel, Tomoko, Wickline, Samuel A., Pan, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497821/ https://www.ncbi.nlm.nih.gov/pubmed/32954352 http://dx.doi.org/10.26502/jcsct.5079070 |
Ejemplares similares
-
NKILA inhibits NF-κB signaling and suppresses tumor metastasis
por: Ke, Shun, et al.
Publicado: (2018) -
Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma
por: Rauch, Daniel A., et al.
Publicado: (2021) -
microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB
por: Giles, Keith M., et al.
Publicado: (2016) -
Development of a peptide-siRNA nanocomplex targeting NF- κB for efficient cartilage delivery
por: Yan, Huimin, et al.
Publicado: (2019) -
IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF-κB signaling pathway
por: Wang, Mengxue, et al.
Publicado: (2023)